Profile
H.
Michael Shepard was the founder of Receptor BioLogix, Inc. (founded in 2003, titles: President & Chief Scientific Officer) and Enosi Life Sciences Corp.
(founded in 2018, titles: President, Director & Chief Scientific Officer).
Former jobs include Independent Director at Nevis Brands, Inc., Principal at Genentech, Inc. (1980-1992), Chief Scientific Officer & Vice President at Halozyme Therapeutics, Inc. (2012-2017), President & Chief Scientific Officer at NewBiotics, Inc. (1997-2008), and Chief Scientific Officer & Vice President-Research at Canji, Inc. (1992-1997).
Education includes a doctorate from Indiana University and an undergraduate degree from the University of California, Davis.
H. Shepard active positions
| Companies | Position | Start |
|---|---|---|
Enosi Life Sciences Corp.
Enosi Life Sciences Corp. BiotechnologyHealth Technology Operates as a drug research and development company | Founder | 2018-08-15 |
Former positions of H. Shepard
| Companies | Position | End |
|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2017-01-31 |
Receptor BioLogix, Inc.
Receptor BioLogix, Inc. BiotechnologyHealth Technology Offers receptor based biological therapeutics | Founder | 2008-01-01 |
NewBiotics, Inc.
NewBiotics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | President | 2007-12-31 |
Canji, Inc.
Canji, Inc. Medical/Nursing ServicesHealth Services Gene therapy research | Chief Tech/Sci/R&D Officer | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Training of H. Shepard
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets | Health Technology |
NewBiotics, Inc.
NewBiotics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
Receptor BioLogix, Inc.
Receptor BioLogix, Inc. BiotechnologyHealth Technology Offers receptor based biological therapeutics | Health Technology |
Canji, Inc.
Canji, Inc. Medical/Nursing ServicesHealth Services Gene therapy research | Health Services |
Indiana University
Indiana University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nevis Brands, Inc.
Nevis Brands, Inc. BiotechnologyHealth Technology Engages in the research on the field of immunotherapy | Health Technology |
Enosi Life Sciences Corp.
Enosi Life Sciences Corp. BiotechnologyHealth Technology Operates as a drug research and development company | Health Technology |
- Stock Market
- Insiders
- H. Shepard
















